-
Purpose(Empty Backbone) Tetracycline inducible expression of shRNA targeted to AAVS1 locus
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 86695 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneAAVS1 SA-2A-puro-pA donor Addgene 22075
-
Backbone manufacturerRudolf Jaenisch
- Backbone size (bp) 9487
-
Modifications to backboneBglII site removed, H1 TO sequence added in HincII site, CAG-OPTtetR-pA added in at pspXI blunt ended site.
-
Vector typeMammalian Expression
- Promoter H1 TO
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer CGAACGCTGACGTCATCAACC
- 3′ sequencing primer GGGCTATGAACTAATGACCCCG (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byH1-TO promoter taken from pSuperior Neo (oligoengine)
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please see https://www.researchgate.net/publication/323464587_Conditional_Manipulation_of_Gene_Function_in_Human_Cells_with_Optimized_Inducible_shRNA_Optimized_Inducible_Gene_Knockdown_in_hPSCs for an additional methods chapter utilizing this plasmid
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV-Puro_siKD was a gift from Ludovic Vallier (Addgene plasmid # 86695 ; http://n2t.net/addgene:86695 ; RRID:Addgene_86695) -
For your References section:
Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs. Bertero A, Pawlowski M, Ortmann D, Snijders K, Yiangou L, Cardoso de Brito M, Brown S, Bernard WG, Cooper JD, Giacomelli E, Gambardella L, Hannan NR, Iyer D, Sampaziotis F, Serrano F, Zonneveld MC, Sinha S, Kotter M, Vallier L. Development. 2016 Dec 1;143(23):4405-4418. 10.1242/dev.138081 PubMed 27899508